In conversation with Matthew Laurens: clinical research, malaria vaccines, and global access
Vaccine Insights 2026; 5(1), 39–41
DOI: 10.18609/vac.2026.009
Published: 16 February
Interview
Matthew Laurens reflects on how early exposure to vaccine-preventable disease in resource-limited settings guided his career in vaccinology, and the ways in which that perspective informs his work on whole-organism malaria vaccines. He discusses the clinical potential of these approaches, the realities of large-scale deployment, and the role of implementation science in advancing global vaccine impact.
